Accupril recall: CGMP Deviations
Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
Why was Accupril recalled?
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots: DX8682 Exp. MAR 31 2023; DG1188 Exp. MAR 31 2022
- Product
- Accupril (Quinapril HCl Tablets) 20 mg, 90 Tablets, Rx only NDC 0071-0532-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
- Recalling firm
- Pfizer Inc.
- Quantity
- 10,304 bottles
- Distribution
- Nationwide and Puerto Rico
- Recall date
- May 25, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)